# Dose Escalation of Different Concentrations of ZK 245186 in Atopic Dermatitis

> **NCT00944632** · PHASE2 · COMPLETED · sponsor: **Bayer** · enrollment: 64 (actual)

## Conditions studied

- Atopic Dermatitis

## Interventions

- **DRUG:** ZK 245186
- **DRUG:** Placebo (vehicle ointment)

## Key facts

- **NCT ID:** NCT00944632
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-07-15
- **Primary completion:** 2010-09-15
- **Final completion:** 2010-09-15
- **Target enrollment:** 64 (ACTUAL)
- **Last updated:** 2023-06-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00944632

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00944632, "Dose Escalation of Different Concentrations of ZK 245186 in Atopic Dermatitis". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00944632. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*